Relaxing incisions
Jonathan Rubenstein, MD, gives context to incisional astigmatic correction
May 2020 Feature: Revolution in Glaucoma Medications Read this Issue
-
The first sustained-release medication for glaucoma, an intracameral implant, was approved by the FDA in March -
The three recently approved agents for the treatment of glaucoma excluding sustained- release drugs are... -
Maximum medical therapy is better defined as maximum tolerated medical therapy -
There are many potential barriers to adherence in glaucoma medical therapy
Trending Videos
-
https://youtu.be/LOMtkRkxcfw
Artificial iris implant
Kevin Miller, MD, discusses a new implant for the treatment of iris defects -
https://youtu.be/XE3d22XFcSs
Important considerations for toric IOLs
Nicole Fram, MD, discusses pearls for pre-, peri-, and postoperative management for toric IOL cases -
https://youtu.be/-6BlizbRWcw
Pre-cataract surgery workup
Steve Charles, MD, discusses pre-cataract surgery workup -
https://youtu.be/-VTNDEb8vIk
Snaring the loose IOL
Nick Mamalis, MD, discusses snaring the loose IOL -
https://youtu.be/eyu074BAi3E
Anti-inflammatory delivery beyond drops
Michael Patterson, DO, discusses anti-inflammatory delivery beyond drops
Supplements View Archives: CME Non-CME
-
DEC 2019: Managing ocular surface disease in a preoperative cataract or refractive surgery patient -
DEC 2019: Improving the cataract patient experience: Minimizing pain and inflammation while reducing the need for topical drops -
November 2019: Toric Toolbox: Building skills and strategies to surgically manage astigmatism -
September 2019: Meibography Summit: Better understanding of meibomian gland dysfunction and how to integrate meibography in diagnosis and treatment planning -
July 2019: Advancing Surgical Outcomes: Algorithm launches new era in preoperative OSD management -
May 2019: Innovations advancing cataract surgery -
May 2019: Therapeutic solutions: Ocular surface disease and episodic flares of dry eye disease -
October 2018: Examining meibomian gland dysfunction and its impact -
March 2018: Customizing modern OSD therapies to individual patient needs
